-
June 1, 2023 The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked OffThe largest Phase 3 clinical trial investigating the efficacy and tolerability of psilocybin for treatment-resistant...
-
May 30, 2023 Single Dose of Psilocybin Yields Long-Term Depression Remission in Over 50% of Cancer PatientsA single 25mg dose of psilocybin paired with psychological support has resulted in 57% of...
-
September 30, 2022 Math Over Myth: September Psychedelic Stock News RoundupTrack the monthly performance of the psychedelic stock sector with our Math over Myth Stock...
